Neonatal Outcomes in Maternal Depression in Relation to Intrauterine Drug Exposure
Background: SSRIs (Selective Serotonin Reuptake Inhibitors) are the most useful drugs to treat depression during pregnancy. Intrauterine exposure to SSRIs may increase the risk of growth restriction, preterm birth and neonatal complications. However, advantages in treating depression seem to exceed...
Saved in:
Main Authors: | Silvia Corti (Author), Paola Pileri (Author), Martina I. Mazzocco (Author), Chiara Mandò (Author), Anna F. Moscatiello (Author), Dario Cattaneo (Author), Stefania Cheli (Author), Sara Baldelli (Author), Laura Pogliani (Author), Emilio Clementi (Author), Irene Cetin (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2019-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Therapeutic Drug Monitoring of Anti-TNFα Inhibitors: A Matter of Cut-Off Ranges
by: Stefania Cheli, et al.
Published: (2023) -
LightSNiP assay is a good strategy for Pharmacogenetics Test
by: Stefania eCheli, et al.
Published: (2015) -
Cryopreserved placental biopsies maintain mitochondrial activity for high-resolution respirometry
by: Matteo Giovarelli, et al.
Published: (2023) -
Inflammation and neurological adverse drugs reactions: a case of long lasting impaired consciousness after oxatomide administration in a patient with gastroenteritis
by: Antoniazzi Stefania, et al.
Published: (2012) -
Response to: “Challenges in DPYD Test Implementation in Patients Treated with Fluoropyirimidines, is DPYD Genotype Arriving on Time?” [Response to Letter]
by: Montrasio C, et al.
Published: (2024)